These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21471511)

  • 1. Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance.
    Mulvihill EE; Assini JM; Lee JK; Allister EM; Sutherland BG; Koppes JB; Sawyez CG; Edwards JY; Telford DE; Charbonneau A; St-Pierre P; Marette A; Huff MW
    Diabetes; 2011 May; 60(5):1446-57. PubMed ID: 21471511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance.
    Mulvihill EE; Allister EM; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Markle JM; Hegele RA; Huff MW
    Diabetes; 2009 Oct; 58(10):2198-210. PubMed ID: 19592617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
    Tsai J; Qiu W; Kohen-Avramoglu R; Adeli K
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nobiletin Prevents High-Fat Diet-Induced Dysregulation of Intestinal Lipid Metabolism and Attenuates Postprandial Lipemia.
    Morrow NM; Trzaskalski NA; Hanson AA; Fadzeyeva E; Telford DE; Chhoker SS; Sutherland BG; Edwards JY; Huff MW; Mulvihill EE
    Arterioscler Thromb Vasc Biol; 2022 Feb; 42(2):127-144. PubMed ID: 34911361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alleviating VLDL overproduction is an important mechanism for Laminaria japonica polysaccharide to inhibit atherosclerosis in LDLr
    Zha XQ; Zhang WN; Peng FH; Xue L; Liu J; Luo JP
    Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27928899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
    Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
    Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice.
    Han S; Liang CP; Westerterp M; Senokuchi T; Welch CL; Wang Q; Matsumoto M; Accili D; Tall AR
    J Clin Invest; 2009 Apr; 119(4):1029-41. PubMed ID: 19273907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
    Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
    Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
    Bojic LA; Burke AC; Chhoker SS; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Tirona RG; Yin H; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):52-60. PubMed ID: 24158519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sterol carrier protein-2 deficiency attenuates diet-induced dyslipidemia and atherosclerosis in mice.
    He H; Wang J; Yannie PJ; Kakiyama G; Korzun WJ; Ghosh S
    J Biol Chem; 2018 Jun; 293(24):9223-9231. PubMed ID: 29700117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.
    Kim DH; Zhang T; Lee S; Calabuig-Navarro V; Yamauchi J; Piccirillo A; Fan Y; Uppala R; Goetzman E; Dong HH
    Endocrinology; 2014 Apr; 155(4):1255-67. PubMed ID: 24437489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
    Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
    Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of protein kinase C betaII/epsilon-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin.
    Miyata Y; Sato T; Yano M; Ito A
    Mol Cancer Ther; 2004 Jul; 3(7):839-47. PubMed ID: 15252145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
    Khound R; Taher J; Baker C; Adeli K; Su Q
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
    Qin B; Anderson RA; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p38 mitogen-activated protein kinase-dependent transactivation of ErbB receptor family: a novel common mechanism for stress-induced IRS-1 serine phosphorylation and insulin resistance.
    Hemi R; Yochananov Y; Barhod E; Kasher-Meron M; Karasik A; Tirosh A; Kanety H
    Diabetes; 2011 Apr; 60(4):1134-45. PubMed ID: 21386087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The citrus flavonoid nobiletin confers protection from metabolic dysregulation in high-fat-fed mice independent of AMPK.
    Morrow NM; Burke AC; Samsoondar JP; Seigel KE; Wang A; Telford DE; Sutherland BG; O'Dwyer C; Steinberg GR; Fullerton MD; Huff MW
    J Lipid Res; 2020 Mar; 61(3):387-402. PubMed ID: 31964763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An experimental study on amelioration of dyslipidemia-induced atherosclesis by Clematichinenoside through regulating Peroxisome proliferator-activated receptor-α mediated apolipoprotein A-I, A-II and C-III.
    Liu C; Guo Q; Lu M; Li Y
    Eur J Pharmacol; 2015 Aug; 761():362-74. PubMed ID: 25979856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-α.
    Lucero D; Miksztowicz V; Macri V; López GH; Friedman S; Berg G; Zago V; Schreier L
    Clin Investig Arterioscler; 2015; 27(4):167-74. PubMed ID: 25796423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression.
    Duan Y; Chen Y; Hu W; Li X; Yang X; Zhou X; Yin Z; Kong D; Yao Z; Hajjar DP; Liu L; Liu Q; Han J
    J Biol Chem; 2012 Jul; 287(28):23667-77. PubMed ID: 22593575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.